Conference abstractPublished 25 Aug 2025
Long-term tolerance of dense-dose temozolomide and the development of secondary diffuse large b-cell lymphoma in a patient with anaplastic astrocytoma
United Kingdom
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
Temozolomide (TMZ) is a standard treatment for high-grade gliomas like anaplastic astrocytoma. While short-term toxicity profiles are well-documented, there is limited evidence on long-term tolerance and rare complications such as secondary malignancies or paraneoplastic syndromes. This case explores the clinical course of a patient who tolerated dense-dose TMZ for 5 years without major side effects but later developed diffuse large B-cell lymphoma (DLBCL) and paraneoplastic pemphigus—highlighting potential underrecognized risks in long-term management. Methodology & Theoretical Orientation: This retrospective case study analyzed the clinical progression, radiological stability, and complications in a 57-year-old male diagnosed with anaplastic astrocytoma (IDH1 wild-type, 1p/19q non-deleted) in 2015. Treatment history, radiology, histopathology, and follow-up records over 10 years were reviewed to identify correlations between prolonged TMZ exposure and subsequent complications. The case is framed within a clinical oncology context, exploring oncological decision-making, treatment resilience, and secondary disease monitoring. Findings: Following initial surgery, radiotherapy, and adjuvant TMZ, the patient received dense-dose TMZ for 5 years with excellent disease control and minimal side effects. In 2023, he developed DLBCL, treated successfully with R-CHOP. Subsequently, he developed paraneoplastic pemphigus without evidence of glioma recurrence or lymphoma relapse. Despite complex events, MRI scans consistently showed stable brain disease from 2017 to 2025. Conclusion & Significance: This case demonstrates that long-term TMZ therapy can be well-tolerated and effective, but rare complications such as secondary lymphomas and paraneoplastic syndromes can emerge. It emphasizes the importance of extended follow-up and vigilance for late effects in long-term survivors. Oncology services should consider risk stratification and regular systemic surveillance for patients receiving extended chemotherapy.
Subjects
Neuroscience & NeurologyAsk about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
Conferences in this field
Upcoming conferences in this field.
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalNeurological Disorders
- SubjectNeuroscience & Neurology
- BylineArticles whose byline prints “Zahra Nawaz”
